311 POSTER In vivo antitumor efficacy of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor

A.Iwahara; T.Tamura; S.Takagi; H.Kamiguchi; T.Yusa; Y.Ohta

首页> 外文期刊>European Journal of Cancer Supplements >311 POSTER In vivo antitumor efficacy of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor

【24h】

311 POSTER In vivo antitumor efficacy of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor

机译：311 POSTER新型ErbB1 / ErbB2双激酶抑制剂TAK-285的体内抗肿瘤功效

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第12期|共2页
作者
A.Iwahara; T.Tamura; S.Takagi; H.Kamiguchi; T.Yusa; Y.Ohta;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 311 POSTER In vivo antitumor efficacy of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor [J] . A.Iwahara, T.Tamura, S.Takagi, European Journal of Cancer Supplements . 2008,第12期

机译：311 POSTER新型ErbB1 / ErbB2双激酶抑制剂TAK-285的体内抗肿瘤功效
2. 314 POSTER Combined antitumor efficacies of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor, with other anticancer drugs [J] . T.Tamura, S.Takagi, K.Horikoshi, European Journal of Cancer Supplements . 2008,第12期

机译：314 POSTER新型ErbB1 / ErbB2双激酶抑制剂TAK-285与其他抗癌药的联合抗肿瘤作用
3. 313 POSTER Novel inhibitory mechanisms of TAK-285, a new EGFR/ErbB2 dual inhibitor [J] . S.A.Shell, K.J.Pry, P.Trusk, European Journal of Cancer Supplements . 2008,第12期

机译：313 POSTER新型EGFR / ErbB2双重抑制剂TAK-285的新型抑制机制
4. In Vitro Metabolism of an ERBB2 Receptor Tyrosine Kinase Inhibitor: Identification of Metabolites by LC/MS/MS, LC-NMR and Wet Chemistry Techniques [C] . Chandra Prakash, Zhuang Miao, Jie Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2007

机译：ERBB2受体酪氨酸激酶抑制剂的体外代谢：通过LC / MS / MS，LC-NMR和湿化学技术鉴定代谢物
5. Paradoxical GCN2 Kinase Activation Enhances Antitumor Activity of Kinase Inhibitors [D] . Tang, Colin P. 2021

机译：矛盾的GCN2激酶活化可增强激酶抑制剂的抗肿瘤活性
6. Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells [O] . Maggie J Rathos, Harshal Khanwalkar, Kavita Joshi, 2013

机译：细胞周期蛋白依赖性激酶抑制剂P276-00在人非小细胞肺癌细胞中增强阿霉素的体外和体内抗肿瘤功效
7. Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models [O] . Tsuyoshi Suzuki, Akihiro Fujii, Junichi Ohya, 2009

机译：小鼠异种移植模型中双表皮生长因子受体和ERBB2激酶抑制剂MP-412（AV-412）的抗肿瘤活性
8. Novel Screen for Suppressors of Breast Tumor Cell Growth Using an Oriented Random Peptide Library Method to Identify Inhibitors of the ErbB2 Tyrosine Kinase [R] . Carraway, K. 2000

机译：使用定向随机肽库方法鉴定ErbB2酪氨酸激酶抑制剂的新型乳腺肿瘤细胞生长抑制剂筛选

311 POSTER In vivo antitumor efficacy of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor

著录项

相似文献

相关主题

期刊订阅